"FDA Commissioner Testifies on Hemp Regulations and Food Safety Oversight at Congressional Hearing"

FDA Commissioner Robert Califf urges the DEA not to delay in making a decision on rescheduling marijuana, emphasizing the need for a regulatory scheme for cannabis. He also highlights the complexities of regulating cannabis, especially in the context of medical and recreational use. Meanwhile, the FDA is facing criticism for its refusal to regulate hemp products like CBD, with lawmakers expressing concerns about the lack of regulations and the potential dangers to consumers. The Biden administration continues to push for marijuana reform, with President Biden issuing cannabis pardons and Vice President Harris advocating for the DEA to expedite its review and rescheduling process.